Common Blood Pressure Pill Recalled Nationwide
The U.S. Food and Drug Administration said the recalled medication, chlorthalidone, doesn’t dissolve properly, which could impact its potency. Learn which lots were affected.

Published on October 01, 2026
More than 25,000 bottles of the blood pressure medication chlorthalidone have been recalled because the tablets may not dissolve correctly in the body, according to the U.S. Food and Drug Administration (FDA).
Chlorthalidone is a diuretic drug prescribed to treat high blood pressure, per Mayo Clinic. Diuretics reduce the amount of water in the body, which helps to lower blood pressure.
The India-based manufacturer, Inventia Healthcare, first recalled about 11,500 bottles of generic 25 milligram (mg) chlorthalidone tablets in June. The company issued a secondary recall of about 13,500 more bottles on September 3, 2026. The FDA lists both recalls as class 2, meaning the medication could “cause temporary or medically reversible adverse health consequences,” and that the likelihood of serious complications is remote.
The recalled bottles were distributed nationwide, according to the FDA reports. The recalled batches have an expiration date of 04/2027, and bear the following lot codes:
- RISA24001
- RISA24002
- RISB24002
The name of a drug’s manufacturer and lot numbers can often be found on the label of your medication.
For class 2 recalls, the FDA says you “can generally continue taking the medicine unless the recalling company provides other instructions.” It may be risky to your health to stop taking the recalled medication without a replacement. If you have concerns about your medicine, reach out to your pharmacy or healthcare provider.
EDITORIAL SOURCES
Everyday Health follows strict sourcing guidelines to ensure the accuracy of its content, outlined in our editorial policy. We use only trustworthy sources, including peer-reviewed studies, board-certified medical experts, patients with lived experience, and information from top institutions.
Resources
- Enforcement Report No. 99806. U.S. Food and Drug Administration. September 17, 2026.
- Enforcement Report No. 99136. U.S. Food and Drug Administration. June 22, 2026.
- Chlorthalidone (Oral Route). Mayo Clinic.
- Recalls Background and Definitions. U.S. Food and Drug Administration. July 31, 2014.
- Understanding Drug Recalls: What to Know and What to Do. U.S. Food and Drug Administration. May 6, 2026.
Meet Our Experts

Emily Kay Votruba
Fact-Checker
Emily Kay Votruba has copy edited and fact-checked for national magazines, websites, and books since 1997, including Self, GQ, Gourmet, Golf Magazine, Outside, Cornell University P...

Monroe Hammond
Author
Monroe Hammond joined Everyday Health in 2021 and now runs the news desk as an editor. They received a master’s degree from the Newmark Graduate School of Journalism at CUNY, as we...